UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data

American journal of obstetrics and gynecology, 2012-02, Vol.206 (2), p.124.e1-124.e19

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

The Lancet global health, 2019-08, Vol.7 (8), p.e1054-e1064

2019

Link zum Volltext

Verfügbarkeit prüfen

Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data

American journal of obstetrics and gynecology, 2018-02, Vol.218 (2), p.161-180

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis

American journal of obstetrics and gynecology, 2018-07, Vol.219 (1), p.10-25

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial

Clinical obstetrics and gynecology, 2024-06, Vol.67 (2), p.433

2024

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics

Journal of acquired immune deficiency syndromes (1999), 2016-12, Vol.73 (5), p.489

2016

Link zum Volltext

Verfügbarkeit prüfen

Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data

Fertility and sterility, 2002-02, Vol.77 (2 Suppl 2), p.13-18

2002

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa

Antimicrobial agents and chemotherapy, 2016-09, Vol.60 (9), p.5459-5466

2016

Link zum Volltext

Verfügbarkeit prüfen

Vaginal Progesterone Is as Effective as Cervical Cerclage to Prevent Preterm Birth in Women With a Singleton Gestation, Previous Spontaneous Preterm Birth, and a Short Cervix: Updated Indirect Comparison Meta-analysis

Obstetrical & gynecological survey, 2018-12, Vol.73 (12), p.674-676

2018

Link zum Volltext

Verfügbarkeit prüfen

Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women

Fertility and sterility, 2002-02, Vol.77 (2 Suppl 2), p.27-31

2002

Link zum Volltext

Verfügbarkeit prüfen

The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacy

Contraception (Stoneham), 2004-03, Vol.69 (3), p.189-195

2004

Link zum Volltext

Verfügbarkeit prüfen

490: Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial

American journal of obstetrics and gynecology, 2012, Vol.206 (1), p.S223-S223

2012

Link zum Volltext

Verfügbarkeit prüfen

Ortho Evra ™/Evra ™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error

Fertility and sterility, 2003-07, Vol.80 (1), p.34-42

2003

Link zum Volltext

Verfügbarkeit prüfen

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™)

Fertility and sterility, 2002-02, Vol.77 (2 Suppl 2), p.19-26

2002

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a transdermal contraceptive system

Obstetrics and gynecology (New York. 1953), 2001, Vol.98 (5), p.799-805

2001

Link zum Volltext

Verfügbarkeit prüfen

Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditions

Fertility and sterility, 2002-02, Vol.77 (2 Suppl 2), p.32-35

2002

Link zum Volltext

Verfügbarkeit prüfen

Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study

American journal of obstetrics and gynecology, 2002-01, Vol.186 (1), p.15-20

2002

Link zum Volltext

Verfügbarkeit prüfen

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INDUCTION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Fertility and sterility, 2021-09, Vol.116 (3), p.e47-e47

2021

Link zum Volltext

Verfügbarkeit prüfen

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INHIBITION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Fertility and sterility, 2021-09, Vol.116 (3), p.e48-e48

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise

Journal of clinical pharmacology, 2001-12, Vol.41 (12), p.1301-1309

2001

Link zum Volltext

Verfügbarkeit prüfen

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human

American journal of obstetrics and gynecology, 1994-02, Vol.170 (2), p.474-478

1994

Link zum Volltext

Verfügbarkeit prüfen

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20

Contraception (Stoneham), 2001-06, Vol.63 (6), p.289-295

2001

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2001-05, Vol.285 (18), p.2347

2001

Link zum Volltext

Verfügbarkeit prüfen

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties

Contraception (Stoneham), 2003-02, Vol.67 (2), p.93-99

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Female
(36)
Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Obstetrics & Gynecology
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Adult
(21)
Pregnancy
(21)
Administration, Cutaneous
(13)
Ethinyl Estradiol - Administration & Dosage
(12)
Gynecology. Andrology. Obstetrics
(11)
Norgestrel - Analogs & Derivatives
(11)
Pharmacology. Drug Treatments
(11)
Adolescent
(10)
Contraceptives, Oral, Combined - Administration & Dosage
(10)
Ethinyl Estradiol
(10)
Oximes
(10)
Ethisterone - Analogs & Derivatives
(9)
Genital System. Reproduction
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data

Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis

Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial

Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics

Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data

In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa

Vaginal Progesterone Is as Effective as Cervical Cerclage to Prevent Preterm Birth in Women With a Singleton Gestation, Previous Spontaneous Preterm Birth, and a Short Cervix: Updated Indirect Comparison Meta-analysis

Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women

The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacy

490: Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial

Ortho Evra ™/Evra ™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™)

Efficacy and safety of a transdermal contraceptive system

Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditions

Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INDUCTION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INHIBITION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20

Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties

Suchergebnisse filtern